WO2024039450A1 - Techniques de détermination et de gestion de score de fatigue de condition physique - Google Patents
Techniques de détermination et de gestion de score de fatigue de condition physique Download PDFInfo
- Publication number
- WO2024039450A1 WO2024039450A1 PCT/US2023/026837 US2023026837W WO2024039450A1 WO 2024039450 A1 WO2024039450 A1 WO 2024039450A1 US 2023026837 W US2023026837 W US 2023026837W WO 2024039450 A1 WO2024039450 A1 WO 2024039450A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- user
- data
- period
- time
- fitness
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 90
- 230000007958 sleep Effects 0.000 claims abstract description 125
- 238000009532 heart rate measurement Methods 0.000 claims abstract description 30
- 230000037081 physical activity Effects 0.000 claims description 20
- 238000005259 measurement Methods 0.000 claims description 18
- 230000000284 resting effect Effects 0.000 claims description 12
- 230000035882 stress Effects 0.000 description 99
- 230000000694 effects Effects 0.000 description 47
- 230000033001 locomotion Effects 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- 238000004891 communication Methods 0.000 description 16
- 238000013459 approach Methods 0.000 description 15
- 238000004422 calculation algorithm Methods 0.000 description 15
- 238000012544 monitoring process Methods 0.000 description 14
- 230000036541 health Effects 0.000 description 12
- 210000002820 sympathetic nervous system Anatomy 0.000 description 12
- 238000010586 diagram Methods 0.000 description 11
- 230000015654 memory Effects 0.000 description 9
- 230000003287 optical effect Effects 0.000 description 9
- 230000009471 action Effects 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 238000012806 monitoring device Methods 0.000 description 6
- 230000036651 mood Effects 0.000 description 6
- 206010038743 Restlessness Diseases 0.000 description 5
- 230000009894 physiological stress Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000002791 sympathovagal effect Effects 0.000 description 5
- 230000003442 weekly effect Effects 0.000 description 5
- 208000001431 Psychomotor Agitation Diseases 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 230000006855 networking Effects 0.000 description 4
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 3
- 238000013500 data storage Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 230000004461 rapid eye movement Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 230000003938 response to stress Effects 0.000 description 3
- 230000004043 responsiveness Effects 0.000 description 3
- 230000004620 sleep latency Effects 0.000 description 3
- 230000008667 sleep stage Effects 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000010482 emotional regulation Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000004617 sleep duration Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 230000003936 working memory Effects 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000037326 chronic stress Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000000537 electroencephalography Methods 0.000 description 1
- 238000002567 electromyography Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 230000006388 psychological stress response Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0531—Measuring skin impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/681—Wristwatch-type devices
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0531—Measuring skin impedance
- A61B5/0533—Measuring galvanic skin response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1118—Determining activity level
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Cardiology (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Physiology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Developmental Disabilities (AREA)
- Educational Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Un score de fatigue de condition physique pour un utilisateur pour un jour actuel est fourni. Le score de fatigue de condition physique peut être déterminé sur la base, au moins en partie, de premières données obtenues sur une première période de temps, de deuxièmes données obtenues sur une deuxième période de temps qui est plus courte en durée que la première période de temps, et de troisièmes données obtenues sur une troisième période de temps qui est plus longue en durée que la première période de temps. Les premières données comprennent des mesures de fréquence cardiaque pour l'utilisateur sur la première période de temps. Les secondes données comprennent une ou plusieurs métriques de sommeil pour une pluralité d'événements de sommeil pour l'utilisateur sur la seconde période de temps. Les troisièmes données comprennent une variabilité de fréquence cardiaque pour l'utilisateur sur la troisième période de temps. De plus, une recommandation concernant l'exercice pour le jour actuel peut être générée sur la base du score de fatigue de condition physique.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/891,428 | 2022-08-19 | ||
| US17/891,428 US20220406453A1 (en) | 2020-08-07 | 2022-08-19 | Fitness Fatigue Score Determination and Management Techniques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024039450A1 true WO2024039450A1 (fr) | 2024-02-22 |
Family
ID=87550921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2023/026837 WO2024039450A1 (fr) | 2022-08-19 | 2023-07-03 | Techniques de détermination et de gestion de score de fatigue de condition physique |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2024039450A1 (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180116607A1 (en) * | 2016-10-28 | 2018-05-03 | Garmin Switzerland Gmbh | Wearable monitoring device |
| US20190183412A1 (en) * | 2016-08-08 | 2019-06-20 | Koninklijke Philips N.V. | System and method for assisting exercising of a subject |
| WO2022031671A1 (fr) * | 2020-08-07 | 2022-02-10 | Fitbit, Inc. | Techniques de détermination et de gestion de stress |
-
2023
- 2023-07-03 WO PCT/US2023/026837 patent/WO2024039450A1/fr unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190183412A1 (en) * | 2016-08-08 | 2019-06-20 | Koninklijke Philips N.V. | System and method for assisting exercising of a subject |
| US20180116607A1 (en) * | 2016-10-28 | 2018-05-03 | Garmin Switzerland Gmbh | Wearable monitoring device |
| WO2022031671A1 (fr) * | 2020-08-07 | 2022-02-10 | Fitbit, Inc. | Techniques de détermination et de gestion de stress |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11889994B2 (en) | Menstrual cycle tracking | |
| US11872041B1 (en) | Determining mental health and cognitive state through physiological and other non-invasively obtained data | |
| US11842813B2 (en) | Health monitoring and evaluation system | |
| US11123562B1 (en) | Pain quantification and management system and device, and method of using | |
| US11678838B2 (en) | Automated detection of breathing disturbances | |
| Pierleoni et al. | A smart inertial system for 24h monitoring and classification of tremor and freezing of gait in Parkinson’s disease | |
| US20230111286A1 (en) | Cluster-Based Sleep Analysis | |
| JP2016538927A (ja) | 人間の現在の概日リズムの計算 | |
| CN110366387A (zh) | 测量和评估睡眠质量 | |
| JP7423759B2 (ja) | クラスタベースの睡眠分析の方法、睡眠改善のためのモニタリングデバイスおよび睡眠改善システム | |
| US20220406453A1 (en) | Fitness Fatigue Score Determination and Management Techniques | |
| US20220361788A1 (en) | System and method for measuring acute and chronic stress | |
| CN115802931A (zh) | 检测用户温度和评估呼吸系统病症的生理症状 | |
| WO2024039450A1 (fr) | Techniques de détermination et de gestion de score de fatigue de condition physique | |
| US20220409187A1 (en) | Illness detection with menstrual cycle pattern analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23748871 Country of ref document: EP Kind code of ref document: A1 |